Search

Search Constraints

You searched for: Author/Creator Stone, John H

Search Results

31. Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Issue 9 (9th June 2022)

32. Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis. (10th January 2018)

33. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Issue 1 (9th May 2014)

34. Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al. Issue 8 (28th April 2015)

35. Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism. Issue 1 (29th March 2023)

38. Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. Issue 8 (12th September 2012)

39. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Issue 1 (3rd December 2019)